Table 2. Adverse events (safety population)
Adverse event typePlacebo, n (%) (n = 58)SNG001, n (%)(n = 56)
Any adverse event46 (79.3%)38 (67.9%)
Any adverse event related to study treatment15 (25.9%)15 (26.8%)
Any severe adverse event6 (10.3%)3 (5.4%)
Any serious adverse event2 (3.4%)4 (7.1%)
Any fatal adverse event00
Any adverse event leading to withdrawal from the study00